Free Trial

ZIVO Bioscience (NASDAQ:ZIVO) Stock Price Crosses Above 50-Day Moving Average - What's Next?

ZIVO Bioscience logo with Medical background

Key Points

  • ZIVO Bioscience shares have crossed above their 50-day moving average, trading as high as $14.85.
  • The company has a market capitalization of $56.68 million and a P/E ratio of -3.04, indicating negative earnings.
  • ZIVO focuses on licensing and selling natural bioactive ingredients derived from proprietary algae cultures for applications in human and animal health.
  • Five stocks we like better than ZIVO Bioscience.

Shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVO - Get Free Report) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $14.62 and traded as high as $14.85. ZIVO Bioscience shares last traded at $14.85, with a volume of 462 shares changing hands.

ZIVO Bioscience Price Performance

The firm has a market capitalization of $49.62 million and a PE ratio of -2.66. The company's 50-day simple moving average is $14.74 and its 200 day simple moving average is $15.82.

About ZIVO Bioscience

(Get Free Report)

ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.

See Also

Should You Invest $1,000 in ZIVO Bioscience Right Now?

Before you consider ZIVO Bioscience, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZIVO Bioscience wasn't on the list.

While ZIVO Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.